Relay Therapeutics Inc
(RLAY)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -363,872 | -296,416 | -235,582 | -42,184 | -52,412 |
| Depreciation Amortization | 5,977 | 4,262 | 2,580 | 1,072 | 3,133 |
| Accounts receivable | 74,677 | 74,276 | 74,801 | 75,000 | -75,000 |
| Accounts payable and accrued liabilities | 930 | -1,503 | -867 | -811 | -410 |
| Other Working Capital | 97,344 | 82,364 | 90,829 | 78,081 | -85,170 |
| Other Operating Activity | 110,538 | 102,318 | 86,739 | -64,518 | 107,370 |
| Operating Cash Flow | $-74,406 | $-34,699 | $18,500 | $46,640 | $-102,489 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 529,923 | 494,673 | 464,673 | 386,175 | 350,058 |
| PPE Investments | -3,471 | -2,591 | -855 | -476 | -1,931 |
| Net Acquisitions | -25,298 | -25,215 | -25,132 | N/A | N/A |
| Purchase Of Investment | -980,665 | -653,633 | -646,239 | -619,320 | -266,455 |
| Investing Cash Flow | $-479,511 | $-186,766 | $-207,553 | $-233,621 | $81,672 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 388,090 | 4,078 | 3,176 | 2,055 | 426,509 |
| Financing Cash Flow | $388,090 | $4,078 | $3,176 | $2,055 | $426,509 |
| Beginning Cash Position | 448,524 | 448,524 | 448,524 | 448,524 | 42,832 |
| End Cash Position | 282,697 | 231,137 | 262,647 | 263,598 | 448,524 |
| Net Cash Flow | $-165,827 | $-217,387 | $-185,877 | $-184,926 | $405,692 |
| Free Cash Flow | |||||
| Operating Cash Flow | -74,406 | -34,699 | 18,500 | 46,640 | -102,489 |
| Capital Expenditure | -3,471 | -2,591 | -855 | -476 | -1,931 |
| Free Cash Flow | -77,877 | -37,290 | 17,645 | 46,164 | -104,420 |